| Kelly Seckman, LCSW-C | |
|
1201 Agora Dr, Suite Lb-2, Bel Air, MD 21014-6859 | |
| (410) 836-7332 | |
| (410) 836-7422 |
| Full Name | Kelly Seckman |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1201 Agora Dr, Bel Air, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316247257 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 12310 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Seckman, LCSW-C 1201 Agora Dr, Suite Lb-2, Bel Air, MD 21014-6859 Ph: (410) 836-7332 | Kelly Seckman, LCSW-C 1201 Agora Dr, Suite Lb-2, Bel Air, MD 21014-6859 Ph: (410) 836-7332 |
News Archive
Researchers of the Unit of Medicine Design and Molecular Topology (Department of Physics Chemistry) of the University of Valencia have discovered eight new active molecules against Alzheimer by a novel mechanism of action, different to the currently used medicines. The work has just been published in the "Plos One" magazine.
Many countries have phased out production of nuclear energy because of concerns related to nuclear waste and the risk of nuclear accidents.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has completed its previously announced private placement of common stock and warrants to purchase common stock. Gross proceeds from the offering were approximately $25.3 million. Proceeds from the private placement are expected to be used for general corporate and working capital purposes.
Delcath Systems, Inc. has announced that the first fifty percent (46 of 92) of patients have been enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver.
Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.
› Verified 3 days ago
Julyette E Berry, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1208 E Churchville Rd Ste 300, Bel Air, MD 21014 Phone: 301-204-6199 | |
Ms. Johanna S Wayne, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 336 S Main St Ste 2ca, Bel Air, MD 21014 Phone: 410-688-1058 | |
Mrs. Lydia Ivette Holloway, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 22 Linwood Ave Ste B, Bel Air, MD 21014 Phone: 443-629-8858 | |
Ms. Carla Battle Nolan, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 336 S Main St, Bel Air, MD 21014 Phone: 410-836-0820 | |
Rosemary A Dehn, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 22 Linwood Ave, Bel Air, MD 21014 Phone: 410-688-1007 | |
Kristle M Fullerton, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 802 Baltimore Pike, Bel Air, MD 21014 Phone: 443-643-2422 | |
Nickolaus King, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4c North Ave Ste 423, Bel Air, MD 21014 Phone: 410-449-4955 Fax: 443-787-0306 |